Articles tagged with Neurodegenerative Diseases
Researchers at Macquarie University identified rare genetic defects in MND and FTD patients that also cause other neurodegenerative diseases. These short tandem repeat expansions are found in over 20 diseases and may contribute to neuron death.
Researchers at the University of Minnesota have developed a new diagnostic technique called Nano-QuIC, which significantly improves protein-misfolding detection methods. The method reduces detection times from 14 hours to just four hours and increases sensitivity by a factor of ten.
Joshua Chen, a Rice University doctoral alum, has won the prestigious Schmidt Science Fellowship to pursue research in synthetic biology and wirelessly programmable cell therapies for neurodegenerative diseases.
A large study found that people with dementia are at higher risk of self-harm within the first 12 months after diagnosis. The researchers emphasize the importance of providing psychosocial and mental health supports to patients upon diagnosis, particularly men, who are more likely to develop dementia after self-harm.
Researchers discover that brain cells die from lack of energy when autophagy, a natural cleaning process, malfunctions. Compounds boosting NAD levels can improve neuron survival and combat age-related neurodegeneration.
A new automated algorithm enhances the assessment of human neuron survival in synucleinopathy by tracking cell death and markers of neuronal fitness. The developed method offers improved accuracy and consistency compared to manual counting.
Scientists have created a detailed map of human spinal cord cell formation, shedding light on how injuries and diseases arise. The study's findings hold promise for developing new therapies for spinal cord injuries and diseases like ALS.
A new study at Stanford University found a previously unknown cellular pathway for clearing misfolded proteins from the nucleus. This pathway could be a target for therapies of age-related diseases like Alzheimer's, Parkinson's, and Huntington's. Cells use this pathway to manage misfolded proteins in both the cytoplasm and nucleus.
Cedars-Sinai investigators have discovered a novel way to treat amyotrophic lateral sclerosis (ALS) and retinitis pigmentosa using human induced pluripotent stem cells. The new approach uses cells derived from iPSCs that are renewable, scalable, and can delay disease progression in rodents.
Researchers uncover the critical link between cellular energy levels and mitochondrial damage through protein FNIP1. The study reveals that FNIP1 enables communication between AMPK and TFEB, instructing genes to remove damaged mitochondria and create new ones.
Researchers have discovered a link between iron redox and Alzheimer's disease, which could lead to the development of new drugs to treat the condition. The new imaging technique allows for the simultaneous detection of two forms of iron in cells and tissue, providing insights into its role in destroying brain cells.
A recent study published in NeuroImage found that older adults with improved cognitive performance during dual-task walking had flexible neural resource allocation. This discovery suggests a potential method for tracking brain health and identifying individuals at risk of aging-related cognitive decline.
A simple blood test for ALS has been developed using microRNA analysis, which can accurately identify patients with the disease. The test uses a unique protein called L1CAM to concentrate diagnostic particles from extracellular vesicles in the bloodstream.
Researchers at Tohoku University used cryo-electron microscopy to determine the high-resolution 3D structure of human SPCA1a, a protein pump involved in calcium and manganese ion transport. The study provided insights into how the protein works and how mutations can cause Hailey-Hailey disease and other neurodegenerative disorders.
The study reveals that gasdermin E drives changes in neurons that contribute to disease progression, leading to mitochondrial damage and axon degeneration. Inactivating gasdermin E prevents cellular damage and delays the progression of ALS in mice.
Scientists from Tokyo Medical and Dental University find that antibody fragments encapsulated in nanomicelles can reduce toxic Aβ species in the brain of an Alzheimer's disease model mouse. This breakthrough delivers treatment to where it is needed most, potentially slowing AD progression.
A new UC Davis study has identified 194 significantly different genes in the brains of people with autism, with many linked to brain connectivity, immune response, and inflammation. The research also found age-dependent differences in genes related to synaptic function and cell loss.
Researchers at UNIGE and UNIL have discovered the importance of cell metabolism in reactivating quiescent neural stem cells, increasing new neurons in adult mice. This breakthrough could lead to potential treatments for conditions like depression and neurodegenerative diseases.
A study found that RNA methylation plays a pivotal role in TDP-43-related neurodegeneration in ALS. The researchers observed highly abundant RNA methylation in the end-stage tissues of patients with ALS. This discovery opens up new avenues for research into the disease, which is linked to environmental exposure.
A team of biologists and engineers created a miniature facility called the Acoustic Gym to study exercise in tiny worms. They found that swimming exercises reduced neurodegeneration in genetically engineered worms with Parkinson's-like symptoms, which could lead to new treatments for humans.
A research group at Uppsala University has developed an artificial blood-brain barrier model that can validate the effectiveness of antibodies in reaching the brain. The model allows for the testing of antibodies without the need for animal experimentation, providing a more efficient and cost-effective alternative.
A study published in PNAS reveals how environmental signals interact with genetic information to influence brain cell health and survival. The research highlights a protein called TNK2 that tunes dopamine levels, finding mutations lead to Parkinson's degeneration.
A team of researchers has developed a new method to screen FDA-approved drugs to determine if they could be repurposed or improved to help patients with spinocerebellar ataxia type 5 (SCA5), a rare and debilitating disease. The pipeline uses cutting-edge spectroscopy to examine the interaction between mutant β-III-spectrin and actin, i...
Researchers at the University of Groningen have discovered the exact structure of polydopamine coatings, which could lead to new applications in surface adhesion and neurodegenerative disease treatment. The study found that these coatings form through auto-oxidation, crosslinking and isomerization processes.
Scientists have developed a new method to measure calorimetric quantities at the molecular level with picosecond time resolution. By tracking water's spectroscopic fingerprints in the THz range, researchers can accurately predict protein-rich droplet formation and its dependency on external parameters like temperature.
Researchers at Tufts University School of Medicine found that p97 protein mutations can cause organelle miscommunication, leading to the accumulation of molecules on mitochondria-endoplasmic reticulum contacts. This miscommunication can modulate membrane rigidity and impact interorganelle interactions.
Researchers found that klotho has anti-inflammatory and neuroprotective effects on cultured glial cells, reversing increased secretion of pro-inflammatory cytokines. The study supports klotho's therapeutic potential in pathological processes with a neuroinflammatory component.
Scientists have developed a technique to detect RNA structures in live cells, shedding light on the role of G-quadruplexes in neurodegenerative diseases. The method uses fluorescent spectroscopy and resolves existing limitations in studying these structures in real-time.
A University of Alberta researcher has found that fractalkine triggers the repair of brain damage caused by multiple sclerosis, leading to increased production of vital brain cells. This discovery could potentially halt or reverse MS symptoms by replacing damaged cells with new ones.
A team of researchers from Harvard and MGH developed a soft robotic wearable capable of significantly assisting upper arm and shoulder movement in people with ALS. The device improved range of motion, reduced muscle fatigue, and increased performance of tasks like holding or reaching for objects.
A new study finds that obesity-related neurodegeneration mimics Alzheimer's disease, with grey matter atrophy patterns similar in both groups. The researchers suggest that controlling excess weight could lead to improved health outcomes and slowed cognitive decline.
A new study found that online forums provide a sense of community and hope for people with dementia, filling an important gap in their support after diagnosis. The forums allow users to share experiences and receive emotional support from others going through similar experiences, helping to alleviate feelings of isolation.
Researchers from the University of Tsukuba have found distinct changes in brain activity patterns that can differentiate between Alzheimer's disease and Lewy body dementia. These changes were present before symptoms emerged and could be detected using conventional MRI.
The Cognitive Neuroscience Society Conference in San Francisco will explore the nature of thinking and memory. Highlights include presentations on aging, neurotechnology, and learning.
Researchers from UNIGE observed that negative emotions modify the brains of older adults excessively and over time, particularly in the posterior cingulate cortex and amygdala. This could be prevented with better emotional management, such as meditation, which could limit neurodegeneration.
A new study has identified distinct patterns of circular RNA expression in human ALS muscle tissue, which display disease-specific gradients and could inform about neuromuscular molecular programs in ALS. The research reveals that specific circRNAs are elevated in ALS muscle biopsies but reduced in spinal cord samples from ALS patients.
Researchers have discovered a possible cause of neurodegeneration in the early stages of Alzheimer's disease using fruit flies. The study found that an overabundance of the TOMM40 gene causes marked cell death in the retina, which corresponds to the level of protein produced by the gene.
A team from Brigham and Women's Hospital developed FIND-seq, a method that isolates and analyzes rare astrocytes driving MS inflammation and neurodegeneration. This approach identified signaling pathways controlling the development of pathogenic astrocytes in mice and humans.
Researchers examined associations between APOE ε2 and ε4 alleles, polygenic profiles, and Alzheimer's disease biomarkers. They found links between ε4 alleles with plasma and CSF Aβ42 and CSF tau, as well as differences in associations with tau and Aβ42.
MIT scientists use single-cell profiling to analyze the cellular function of brain cells affected by Alzheimer's disease, identifying five main areas of disruption. The study reveals specific molecular programs and gene regulation changes that could lead to valuable biomarkers and therapeutic interventions.
A recent study has identified common and unique cellular processes in six neurodegenerative diseases, providing new insights into the underlying causes of these conditions. The research used machine learning analysis to compare RNA markers in whole blood samples from patients with distinct diseases, revealing eight shared themes across...
A retrospective cohort study of 28,311 COVID-19 patients in Germany found a significant association between dementia and increased risk of death. The association was weaker than previously reported studies, suggesting potential changes in the impact of dementia on COVID-19 mortality over time.
Scientists at the CRCHUM have identified a protective probiotic for ALS, Lacticaseibacillus rhamnosus HA-114, that prevents neurodegeneration in the C. elegans worm model. The probiotic helps reduce motor disorders and restore balance to impaired energy metabolism, leading to a decrease in neurodegeneration.
Researchers at the University of Bonn discovered that people with chronic epilepsy may have impaired dendritic integration, leading to less specific place cell firing and reduced ability to distinguish familiar from unfamiliar places. Administering a sodium ion channel inhibitor improved memory in animal models.
Researchers tested three widely believed aging treatments in mice and found no impact on aging. A new analytical approach allowed them to measure aging processes more precisely, revealing that these treatments promote general health rather than targeting aging mechanisms.
Researchers at UC San Diego have developed a CRISPR-based therapy that targets and destroys mutant RNA molecules causing Huntington's disease. The approach improved motor coordination and reduced toxic protein levels in mouse models, suggesting a potential new treatment direction.
An interdisciplinary team from Erlangen has found a new treatment for Huntington's disease by accelerating the degradation of a specific messenger molecule necessary for protein synthesis. This reduces the huntingtin level in patients, offering new hope for long-term implementation of RNA-modifying approaches for fatal diseases.
A new laboratory test can measure levels of amyloid beta oligomers in blood samples, detecting toxic proteins up to years before cognitive impairment. The test, SOBA, has shown promising results in identifying individuals at risk or incubating Alzheimer's disease.
Scientists have developed an AI method to pinpoint cells indicative of Alzheimer's disease based on DNA packing in mouse brain images, offering a potential early detection tool. This approach combines multi-scale imaging with artificial intelligence to identify biomarkers for aging-related diseases.
Early stage clinical studies confirm 40Hz sensory stimulation is safe, with no serious adverse effects. The therapy also showed significant neurological and behavioral benefits, including improved brain activity, reduced brain atrophy, and better sleep patterns.
The study uses 3D electron microscopy and live cell imaging to observe molecular tethers between organelles. These dynamic structures are constantly binding and unbinding, altering contact site configuration in response to cellular changes.
A survey by UCI MIND found that media coverage of the FDA's decision made people less willing to volunteer for Alzheimer's pharmaceutical trials. The study highlights the powerful influence of media coverage on scientific research and emphasizes the need for diverse populations in clinical trials.
Researchers identified USP7 as a novel cyclin F-interacting protein that stabilizes cyclin F protein. The study also found that USP7 regulates cyclin F mRNA, with pharmacological inhibition resulting in downregulation of cyclin F mRNA.
A new survey by the European Federation of Dietitians supports moderate coffee consumption as having clear health benefits, including improved alertness and sports performance. The study involved 585 dietitians from across 26 European countries.
A new hallmark of ALS has been identified, revealing that loss of the RNA processing protein SFPQ leads to motor neuron degeneration. Defective mRNAs accumulate in axons and interfere with normal function, pointing to a possible new target for therapy.
A new study published in the journal Nature has identified medin as a key player in Alzheimer's therapies. Medin, a protein that accumulates in the blood vessels of the brain, promotes vascular pathology and cognitive decline. The researchers hope to develop a treatment targeting medin to prevent vascular damage and cognitive decline.
The APOE4 gene variant increases the risk of Alzheimer's disease by disrupting the insulation of brain wiring. Research found that oligodendrocytes mismanage cholesterol, failing to transport fat molecules to myelinate axons. This deficiency may contribute to the pathology and symptoms of Alzheimer's.
Researchers at University of Cambridge found that a thin shell of water surrounding proteins can determine aggregation, with slower movement leading to more clumping. The discovery has significant implications for treating protein misfolding diseases like Parkinson's and Alzheimer's.
A Rice University bioengineer has developed a noninvasive technology to measure gene expression in deep tissues, particularly in the brain. This innovation could improve the monitoring of gene therapy treating neurodegenerative disorders such as epilepsy, ALS, and Huntington's disease.
Researchers have identified a new gene, NUCL-1, in the transparent roundworm C. elegans, which is linked to human neurodegenerative diseases such as ALS and Alzheimer's. The discovery challenges recent theories on the role of nuclear structures in these disorders.